Electron microscopy (EM) plays a major role in diagnosing disease, but its increasing cost contributes to limiting its availability to a handful of metropolitan locations.
Our Liverpool lab assessed other EM platforms to see if they could be modified to increase automation and deliver improved cost efficiencies. In an innovative collaboration with ATA Scientific and Thermo Fisher Scientific International, a low-cost benchtop electron microscope used for engineering and geology was reimagined for use in pathology. It will be used in our Anatomical Pathology laboratories and could have global commercial potential.
This new class of EM can resolve single proteins, viruses and key cellular changes in renal disease, cancer and rare diseases, promising health and economic benefits for patients and the NSW Health system.
This project demonstrates originality and innovation. It’s an example of clinical service delivery continuing to transform via research and industry collaboration